http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-494208-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06086
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-068
filingDate 1967-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19905f71624910f85d7433c5dfb0feb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bff2ea31b41ba6ccda8d4b6f83e4b7b
publicationDate 1970-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-494208-A
titleOfInvention Process for the preparation of N- (L-Lysyl-L-arginyl) -N ', N'-bis (2-chloroethyl) -p-phenylenediamine
abstract N-(L-lysyl-L-arginyl)-N', N'-bis(2-chlorethyl)-p-phenylene diamine (I) and its salts have outstanding cyostatic properties in vivo at low toxicity and are useful for treating malignant tumours and sarcomae. (I) is prepared by acylating L-arginyl-N, N-bis(2-chlorethyl)-p-phenylene diamine with an activated deriv. of an acid R-NH-C(R-HN-(CH2)4)H-COOH (where R are masking groups for blocking the alpha - and epsilon -amino groups of the lysine group) and separating the masking groups by acidolysis or hydrogenolysis, (I) is opt. converted to acid addition salts.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0038357-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0038357-A1
priorityDate 1967-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421338554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409240959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414006700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID781

Total number of triples: 34.